JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online May 11, 2007
J Nucl Med Technol 2007, doi:10.2967/jnmt.106.035402
© 2007 by Society of Nuclear Medicine Technologist Section
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnmt.106.035402v1
35/2/91    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ballani, N. S.
Right arrow Articles by Al-Enezi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballani, N. S.
Right arrow Articles by Al-Enezi, F.

The Value of Quantitative Uptake of 99mTc-MDP and 99mTc-HMPAO White Blood Cells in Detecting Osteomyelitis in Violated Peripheral Bones

Nasser S. Ballani 1*, Fawaz Abu Al-Huda 2, Haider A. Khan 2, Shihab Al-Mohannadi 2, Hanan Mahmood 2, and Farha Al-Enezi 2

1 Biomedical Sciences, Lebanese International University, Beirut, Lebanon; Radiologic Sciences, Kuwait University, Kuwait; Nuclear Medicine Department, Kuwait Center for Specialised Surgery, Kuwait
2 Radiologic Sciences, Kuwait University, Kuwait; Nuclear Medicine Department, Kuwait Center for Specialised Surgery, Kuwait

* To whom correspondence should be addressed. E-mail: nasser.ballani{at}liu.edu.lb.


   Abstract

Our objective in this study was to evaluate whether measurement of quantitative uptake of 99mTc-methylene diphosphate (MDP) and 99mTc-hexamethylpropyleneamine oxime (HMPAO) white blood cells (WBCs) is useful in detecting osteomyelitis in peripheral bony lesions. Methods: Twenty-four patients (12 men and 12 women; age range, 25-72 y) were referred for imaging because of clinically suspected osteomyelitis. They had a traumatic fracture (n = 10), knee prosthesis (n = 5), hip prosthesis (n = 2), diabetic foot (n = 4), or chronic osteomyelitis (n = 3). Three-phase bone scanning and 99mTc-HMPAO WBC studies were performed on all patients within the same week. Regions of interest were drawn over the abnormal bony sites and the contralateral normal sites, and the abnormal-to-normal uptake ratios (A/N ratios) were obtained for both studies. Results: All patients had abnormal findings on 3-phase bone scanning, whereas 17 (71%) had abnormal findings on 99mTc-HMPAO WBC studies, of which 15 were confirmed to be true-positive. In those 15 patients, the mean A/N ratios for 99mTc-MDP and 99mTc-HMPAO WBC were 3.0 ± 1.6 (range, 1.3-6.2) and 1.8 ± 0.3 (range, 1.4-2.2), respectively. In the other 9 patients, whose scan results were clinically confirmed to be true-negative, the mean A/N ratios for 99mTc-MDP and 99mTc-HMPAO WBC were 2.1 ± 1.2 and 1.2 ± 0.2, respectively. In the group with a 99mTc-MDP A/N ratio greater than 2 (n = 15), 87% (13/15) had a high 99mTc-HMPAO WBC A/N ratio (>1.5), including 2 that were false-positive. In the remaining 2 patients, one with chronic osteomyelitis and the other with a recent hip prosthesis, 99mTc-HMPAO WBC ratios were normal. In the group with a bone A/N ratio of less than 2 (n = 9), only 4 patients (44%) were true-positive for acute osteomyelitis. Conclusion: 99mTc-MDP bone scanning alone, with an A/N ratio of more than 2, is useful in detecting osteomyelitis in violated bone except in the case of a recent hip prosthesis or chronic osteomyelitis.

Key Words: 3-phase bone scan, 99mTc-HMPAO WBC, osteomyelitis, quantitative measurements







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2007 by the Society of Nuclear Medicine Technologist Section.